Enepret Incorporated
Lexington, KY Enepret
- UEI
- P3KJFJJR58R4
- CAGE
- 7T4R7
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 541714 Research and Development in Biotechnology (except Nanobiotechnology) Primary
- 325412 Pharmaceutical Preparation Manufacturing
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- 541690 Other Scientific and Technical Consulting Services
- 541990 All Other Professional, Scientific, and Technical Services
- SAM.gov registration date
- Physical address
- 145 Graham Ave a317, Lexington, KY 40506, USA
- Website
- enepret.com
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- Consulting
- SIC code
- 73 Business Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Adjuvant discovery and down-selection for vaccines against infectious and immune-mediated diseases | National Institute of Allergy and Infectious Diseases | $599,526 | |
| Sbir topic 106: production of adjuvant mimics | National Institute of Allergy and Infectious Diseases | $2,996,311 | |
| Evaluating synthetic biology produced triterpene oils in adjuvant formulations | National Institute of Allergy and Infectious Diseases | $224,703 |
About Enepret Incorporated
Enepret Incorporated is a for-profit corporate entity based in Lexington, Kentucky, registered in SAM.gov since February 2017. The company operates as a manufacturer of goods with a specialized focus on scientific research and development, particularly in the biomedical and vaccine research domains. Its primary business appears to center on innovative research related to vaccine technologies and adjuvant development, with a keen emphasis on synthetic biology approaches to infectious disease mitigation.
The company has secured significant federal contract awards from the National Institute of Allergy and Infectious Diseases (NIAID), predominantly through the Small Business Innovation Research (SBIR) program. These contracts include a $599,526 Firm Fixed Price contract focused on "Adjuvant Discovery and Down-Selection for Vaccines against Infectious and Immune-Mediated Diseases" with a completion date of May 31, 2027, and a $2,996,311 SBIR Phase II contract for "Production of Adjuvant Mimics" awarded on August 30, 2022. The contracts are notable for their research-oriented nature, targeting innovative vaccine development strategies, particularly in creating more durable and universal influenza vaccine technologies. Enepret has also received a sub-contract award dated December 5, 2024, labeled "CORETEC-3105 FUNDING". The company's federal contract awards have not been set aside for specific socioeconomic programs, except for the SBIR Phase II contract, which had a total small business set-aside designation.
SBA capabilities narrative
Providing reliable, robust, renewable, cost effective production systems for high value terpenes
Quick answers
What is Enepret Incorporated's UEI?
Enepret Incorporated's Unique Entity ID (UEI) in SAM.gov is P3KJFJJR58R4.
What is Enepret Incorporated's CAGE code?
Enepret Incorporated's CAGE code is 7T4R7.
What is Enepret Incorporated's primary NAICS code?
Enepret Incorporated's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Enepret Incorporated located?
Enepret Incorporated's physical address in SAM.gov is 145 Graham Ave a317, Lexington, KY 40506, USA.
Is Enepret Incorporated registered in SAM.gov?
Yes. Enepret Incorporated's SAM.gov registration is active through August 6, 2027.
What is Enepret Incorporated's most recent federal award?
Enepret Incorporated's most recent federal contract award is Adjuvant discovery and down-selection for vaccines against infectious and immune-mediated diseases (75N93025C00020), from National Institute of Allergy and Infectious Diseases, on June 1, 2025.
On GovTribe
See Enepret Incorporated's full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors